Buchumschlag

Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection

Hepatitis delta virus (HDV) coinfects with hepatitis B virus (HBV) causing the most severe form of viral hepatitis. However, its exact global disease burden remains largely obscure. We aim to establish the global epidemiology, infection mode-stratified disease progression, and clinical outcome of HD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Miao, Zhijiang (VerfasserIn) , Zhang, Shaoshi (VerfasserIn) , Ou, Xumin (VerfasserIn) , Li, Shan (VerfasserIn) , Ma, Zhongren (VerfasserIn) , Wang, Wenshi (VerfasserIn) , Peppelenbosch, Maikel P (VerfasserIn) , Liu, Jiaye (VerfasserIn) , Pan, Qiuwei (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: The journal of infectious diseases
Year: 2019, Jahrgang: 221, Heft: 10, Pages: 1677-1687
ISSN:1537-6613
DOI:10.1093/infdis/jiz633
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/infdis/jiz633
Volltext
Verfasserangaben:Zhijiang Miao, Shaoshi Zhang, Xumin Ou, Shan Li, Zhongren Ma, Wenshi Wang, Maikel P Peppelenbosch, Jiaye Liu, and Qiuwei Pan
Beschreibung
Zusammenfassung:Hepatitis delta virus (HDV) coinfects with hepatitis B virus (HBV) causing the most severe form of viral hepatitis. However, its exact global disease burden remains largely obscure. We aim to establish the global epidemiology, infection mode-stratified disease progression, and clinical outcome of HDV infection.We conducted a meta-analysis with a random-effects model and performed data synthesis.The pooled prevalence of HDV is 0.80% (95% confidence interval [CI], 0.63-1.00) among the general population and 13.02% (95% CI, 11.96-14.11) among HBV carriers, corresponding to 48-60 million infections globally. Among HBV patients with fulminant hepatitis, cirrhosis, or hepatocellular carcinoma, HDV prevalence is 26.75% (95% CI, 19.84-34.29), 25.77% (95% CI, 20.62-31.27), and 19.80% (95% CI, 10.97-30.45), respectively. The odds ratio (OR) of HDV infection among HBV patients with chronic liver disease compared with asymptomatic controls is 4.55 (95% CI, 3.65-5.67). Hepatitis delta virus-coinfected patients are more likely to develop cirrhosis than HBV-monoinfected patients with OR of 3.84 (95% CI, 1.79-8.24). Overall, HDV infection progresses to cirrhosis within 5 years and to hepatocellular carcinoma within 10 years, on average.Findings suggest that HDV poses a heavy global burden with rapid progression to severe liver diseases, urging effective strategies for screening, prevention, and treatment.
Beschreibung:Published online November 28, 2019
Gesehen am 31.03.2021
Beschreibung:Online Resource
ISSN:1537-6613
DOI:10.1093/infdis/jiz633

Ähnliche Einträge